LivaNova (NASDAQ:LIVN) Hits New 1-Year High – Time to Buy?

Shares of LivaNova PLC (NASDAQ:LIVN) reached a new 52-week high on Monday . The company traded as high as $80.96 and last traded at $80.4150, with a volume of 11296 shares trading hands. The stock had previously closed at $79.39.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on LIVN. Mizuho raised their price target on LivaNova from $85.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Piper Sandler reaffirmed an “overweight” rating and set a $85.00 price target on shares of LivaNova in a report on Thursday, February 19th. Stifel Nicolaus set a $80.00 price target on LivaNova in a report on Wednesday, February 25th. Needham & Company LLC raised their price target on LivaNova from $64.00 to $81.00 and gave the company a “buy” rating in a report on Wednesday, February 25th. Finally, Barclays raised their price target on LivaNova from $73.00 to $76.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Six research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $79.38.

LivaNova Stock Performance

The stock has a 50-day moving average of $69.08 and a 200 day moving average of $65.81. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.33 and a quick ratio of 1.11. The stock has a market capitalization of $4.40 billion, a price-to-earnings ratio of 41.11 and a beta of 0.88.

LivaNova (NASDAQ:LIVN) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.98 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.13. The firm had revenue of $362.26 million during the quarter, compared to analyst estimates of $346.05 million. LivaNova had a return on equity of 16.48% and a net margin of 7.48%.The company’s revenue was up 14.3% on a year-over-year basis. During the same period last year, the company earned $0.88 earnings per share. LivaNova has set its FY 2026 guidance at 4.200-4.300 EPS. On average, analysts expect that LivaNova PLC will post 3.73 EPS for the current year.

Insider Buying and Selling

In related news, Director Francesco Bianchi sold 1,800 shares of LivaNova stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $75.75, for a total value of $136,350.00. Following the completion of the sale, the director directly owned 7,228 shares in the company, valued at $547,521. This trade represents a 19.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.35% of the stock is currently owned by insiders.

Institutional Trading of LivaNova

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of LivaNova by 4.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,497 shares of the company’s stock worth $1,394,000 after purchasing an additional 1,360 shares during the period. Goldman Sachs Group Inc. grew its stake in shares of LivaNova by 4.6% during the first quarter. Goldman Sachs Group Inc. now owns 814,974 shares of the company’s stock worth $32,012,000 after purchasing an additional 36,094 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of LivaNova by 10.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 168,863 shares of the company’s stock worth $6,633,000 after purchasing an additional 15,405 shares during the period. Intech Investment Management LLC grew its stake in shares of LivaNova by 19.6% during the first quarter. Intech Investment Management LLC now owns 43,879 shares of the company’s stock worth $1,724,000 after purchasing an additional 7,195 shares during the period. Finally, Strs Ohio acquired a new stake in shares of LivaNova during the first quarter worth $130,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About LivaNova

LivaNova plc is a global medical technology company that develops and manufactures products and therapies for the cardiac surgery and neuromodulation markets. Headquartered in London, United Kingdom, and Houston, Texas, LivaNova serves hospitals, clinics and healthcare providers in more than 100 countries. The company’s primary focus lies in advancing patient care through innovations in heart–lung bypass, cardiac preservation, circulatory support and neurostimulation therapies.

The Cardiac Surgery business unit offers a comprehensive portfolio of products used in cardiopulmonary bypass procedures, including oxygenators, heart–lung machines, arterial filters, cannulae and sutureless heart valves.